HOMEPostContact Us
Posted June 17. 2014 11:05AM

New hepatitis C wonder drug shakes up the health care industry with remarkable success and $1,000/pill price

Click headline or here to open angled item
In December 2013, Sovaldi won approval from the U.S. Food and Drug Administration, and Roth, of San Rafael, Calif., was placed on a 24-week treatment regimen. The cost: $168,000, or an eye-popping $1,000 per pill. The company says Sovaldi’s price reflects its 90 percent-plus cure rate for hepatitis C and the savings that produces by cutting patients’ long-term treatment costs, which can include hospitalizations, surgeries and even liver transplants.